Postinfectious inflammatory disorders: subgroups based on prospective follow-up

Neurology. 2005 Oct 11;65(7):1057-65. doi: 10.1212/01.wnl.0000179302.93960.ad.

Abstract

Background: Acute disseminated encephalomyelitis (ADEM) refers to a monophasic acute multifocal inflammatory CNS disease. However, both relapsing and site-restricted variants, possibly associated with peripheral nervous system (PNS) involvement, are also observed, and a systematic classification is lacking.

Objective: To describe a cohort of postinfectious ADEM patients, to propose a classification based on clinical and instrumental features, and to identify subgroups of patients with different prognostic factors.

Methods: Inpatients of a Neurologic and Infectious Disease Clinic affected by postinfectious CNS syndrome consecutively admitted over 5 years were studied.

Results: Of 75 patients enrolled, 60 fulfilled criteria for ADEM after follow-up lasting from 24 months to 7 years. Based on lesion distribution, patients were classified as encephalitis (20%), myelitis (23.3%), encephalomyelitis (13.3%), encephalomyeloradiculoneuritis (26.7%), and myeloradiculoneuritis (16.7%). Thirty patients (50%) had a favorable outcome. Fifteen patients (25%) showed a relapsing course. Poor outcome was related with older age at onset, female gender, elevated CSF proteins, and spinal cord and PNS involvement. All but two patients received high-dose steroids as first-line treatment, with a positive response in 39 (67%). Ten of 19 nonresponders (53%) benefited from high-dose IV immunoglobulin; 9 of 10 had PNS involvement. The data were not controlled.

Conclusions: A high prevalence of "atypical variants" was found in this series, with site-restricted damage or additional peripheral nervous system (PNS) involvement. Prognosis and response to steroids were generally good, except for some patient subgroups. In patients with PNS involvement and steroid failure, a favorable effect of IV immunoglobulin was observed.

MeSH terms

  • Adult
  • Age Factors
  • Aged
  • Anti-Inflammatory Agents / therapeutic use
  • Brain / immunology
  • Brain / pathology
  • Brain / physiopathology
  • Central Nervous System / immunology
  • Central Nervous System / pathology
  • Central Nervous System / physiopathology*
  • Cohort Studies
  • Encephalomyelitis, Acute Disseminated / classification*
  • Encephalomyelitis, Acute Disseminated / diagnosis*
  • Encephalomyelitis, Acute Disseminated / physiopathology
  • Female
  • Follow-Up Studies
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Male
  • Middle Aged
  • Peripheral Nerves / immunology
  • Peripheral Nerves / pathology
  • Peripheral Nerves / physiopathology*
  • Prognosis
  • Prospective Studies
  • Recurrence
  • Sex Factors
  • Spinal Cord / immunology
  • Spinal Cord / pathology
  • Spinal Cord / physiopathology
  • Spinal Nerve Roots / immunology
  • Spinal Nerve Roots / pathology
  • Spinal Nerve Roots / physiopathology
  • Steroids / therapeutic use
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Immunoglobulins, Intravenous
  • Steroids